Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

The Institute of Allergology at Charité Universitätsmedizin Berlin invites you to a memorial symposium on February 21, 2025 at 10 a.m. to commemorate the life and work of our esteemed colleague Prof. Dr. Marcus Maurer, whose commitment and achievements in the field of allergology and dermatology were invaluable. During the symposium, companions, colleagues, family and friends will talk about his significant contributions to research of mast cell-mediated diseases and share memories of an extraordinary personality.
A live broadcast of the commemorative event is planned.

The newly established Early Clinical Trial Unit (ECTU) at the Fraunhofer ITMP site TNM in Göttingen provides the opportunity to conduct early-phase clinical trials in close cooperation with the University Medical Center Göttingen.
As part of the multicenter phase I clinical trial “RED4MS” study, sponsored by Cellerys, the first patient has now been treated with a novel therapeutic approach for multiple sclerosis. Red blood cells isolated from the patients are coupled with disease-specific antigens through a specialized procedure, and then reintroduced to the patient. The aim of this therapy is to induce immune tolerance, thereby avoiding the conventional immunosuppressive treatment approach.

A panel discussion with invited stem cell researchers took place in Jena as part of the 12th annual conference of the German Stem Cell Network (GSCN). The discussion focused on the current status and future of applied stem cell research. The role of stem cells in research into cancer, diseases of the gastrointestinal tract, therapeutic approaches for diabetes and the discovery of new “old” drugs for rare diseases was explained. Short films presented the research of the scientists involved - including Dr. Ole Pless from the Fraunhofer ITMP location Hamburg.